Breast cancer chemoresistance: emerging importance of cancer stem cells.
about
Breast cancer stem-like cells: clinical implications and therapeutic strategiesBreast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonistResveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/β-catenin signaling pathwayMiR-519d impedes cisplatin-resistance in breast cancer stem cells by down-regulating the expression of MCL-1GATA3 and TRPS1 are distinct biomarkers and prognostic factors in breast cancer: database mining for GATA family members in malignanciesEpithelial to mesenchymal transition by TGFβ-1 induction increases stemness characteristics in primary non small cell lung cancer cell line.The phenotypic radiation resistance of CD44+/CD24(-or low) breast cancer cells is mediated through the enhanced activation of ATM signaling.Targeting the osteosarcoma cancer stem cellAbrogation of p53 function leads to metastatic transcriptome networks that typify tumor progression in human breast cancer xenografts.Targeting breast cancer-initiating/stem cells with melanoma differentiation-associated gene-7/interleukin-24.Getting to the source: selective drug targeting of cancer stem cells.Enhanced enrichment of prostate cancer stem-like cells with miniaturized 3D culture in liquid core-hydrogel shell microcapsulesCell-surface Vimentin: A mislocalized protein for isolating csVimentin(+) CD133(-) novel stem-like hepatocellular carcinoma cells expressing EMT markers.Galectin-3 augments tumor initiating property and tumorigenicity of lung cancer through interaction with β-catenin.MicroRNA-34a suppresses the breast cancer stem cell-like characteristics by downregulating Notch1 pathway.Development of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer.Combined cancer therapy with hyaluronan-decorated fullerene-silica multifunctional nanoparticles to target cancer stem-like cells.Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguityExpression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential.Epithelial-Mesenchymal Transition Phenotype Is Associated with Clinicopathological Factors That Indicate Aggressive Biological Behavior and Poor Clinical Outcomes in Invasive Breast Cancer.The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells.Let-7a regulates mammosphere formation capacity through Ras/NF-κB and Ras/MAPK/ERK pathway in breast cancer stem cellsPrognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer.Drug Resistant Breast Cancer Cell Line Displays Cancer Stem Cell Phenotype and Responds Sensitively to Epigenetic Drug SAHA.Microcirculatory fraction (MCF(I)) as a potential imaging marker for tumor heterogeneity in breast cancer.The prognostic role of cancer stem cells in breast tumors.Enrichment of breast cancer stem-like cells by growth on electrospun polycaprolactone-chitosan nanofiber scaffolds.Targeting tumour-initiating cells to improve the cure rates for triple-negative breast cancer.Hyaluronan metabolism in remodeling extracellular matrix: probes for imaging and therapy of breast cancer.Quantifying tumor vascular heterogeneity with dynamic contrast-enhanced magnetic resonance imaging: a review.Flow cytometry in cancer stem cell analysis and separation.Nestin and other putative cancer stem cell markers in pancreatic cancer.Targeted therapy aimed at cancer stem cells: Wilms' tumor as an example.Oncolytic viral therapy: targeting cancer stem cellsThe Role of MicroRNAs in the Chemoresistance of Breast Cancer.Knockdown of the T-box transcription factor Brachyury increases sensitivity of adenoid cystic carcinoma cells to chemotherapy and radiation in vitro: implications for a new therapeutic principle.Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis.Tumor-Initiating Cells: Emerging Biophysical Methods of Isolation.Regulation of stem cells-related signaling pathways in response to doxorubicin treatment in Hs578T triple-negative breast cancer cells.Oncolytic virus as a cancer stem cell killer: progress and challenges.
P2860
Q26752170-2EDA439E-CF37-4F01-867D-8BE1F79BE540Q28475994-2A14A83B-0ECB-4FCD-83B8-C797FB7A65A7Q28541242-5172A7ED-9937-4EFC-82B9-644A3AC1124AQ33591783-CAC36365-17EF-40DF-969F-F9ADC10B36D2Q33798578-C9550B17-E8AF-4041-B19C-1FBF998F8ABBQ33955042-B3A4A2FE-C142-4A81-85F4-319BCC58C35EQ34025989-7F386E01-966F-4245-95CD-7AEDBCB19BD8Q34335524-F8368E5D-4971-4E6D-A67A-0BF8BCB1A328Q35034285-03B4F8C7-1478-49C5-A418-FDFE9ABE6190Q35101122-73FCD91E-A4C2-4D1D-AAFD-A53C267A4F66Q35156404-D8C3CE13-71CA-4F47-A2D6-07D573268E6BQ35514837-70CC5552-7526-4A50-B358-DF2A9F8C9583Q35598363-2AE4E1AD-592D-484B-8B89-45428051EEFFQ35741579-3B85AD5E-B9C1-4EBA-B676-15593A64A4E8Q35754283-64EE275E-94C5-4ECF-9FB7-AB98237D32BAQ35827788-F6BCE673-37D9-4582-B87F-5BD5A7876701Q36012912-9FCE6ACC-9676-4128-B6DF-5AE7E29CE1EAQ36014411-E19788D2-5A3C-4393-A421-448FBE7B5EA1Q36042570-56433DBC-C0E9-4C2B-AAFF-8E0570ADF129Q36145725-E44F4E88-04AA-4341-A6C5-2CF5FF43D9DFQ36146466-CA655B7A-72F5-4328-B939-BE67C4025D55Q36189380-A602FDB9-AFBA-46BE-93CF-7D9DC25F3532Q36441530-01947F08-CEC8-4C41-B20A-4F9E3CEF5538Q36717485-7CDA94C1-560D-42CB-8960-A27D092613D8Q36821142-43391636-F5BC-4E33-9723-49C9672A249EQ37108555-0187018B-4711-4F2A-B7FE-037C842ECD87Q37601274-4D178483-0EDD-4E48-BA72-C0C8EF866CA0Q37775105-7AFF5462-5730-4A24-982C-A719D0D57BEEQ37832163-C9272832-1B86-4B2B-8261-27AC98354BA9Q37871859-CBBD69B0-07A9-48D6-BDEB-3CDBCE549313Q37981990-9F8F2831-35A6-4EB1-B4D5-56D92AF6A2FBQ38020421-0EF7A2E5-9934-4CCF-8AAD-93BF3AFA0525Q38114000-F1CEA300-6025-465C-8B9C-A975A7E07441Q38212255-FA14BA0E-69F2-4CC4-8770-AAA9B734176EQ38574546-BB935253-7FC4-4624-AD9B-FFCC5AC32F05Q38635079-39E8D7E8-7D97-402B-AB06-6C1D8BFF306DQ38772722-D56F2AA7-F73F-4F05-BD08-4900693DB240Q38824383-2C0B17C3-3DB1-4CE0-8B09-0F95ADABB002Q38851695-D0C6B65E-8684-4123-A9CC-608CB4159AD5Q38881477-6186F6F0-5B08-4C8A-852C-8901CA2C08D1
P2860
Breast cancer chemoresistance: emerging importance of cancer stem cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Breast cancer chemoresistance: emerging importance of cancer stem cells.
@en
Breast cancer chemoresistance: emerging importance of cancer stem cells.
@nl
type
label
Breast cancer chemoresistance: emerging importance of cancer stem cells.
@en
Breast cancer chemoresistance: emerging importance of cancer stem cells.
@nl
prefLabel
Breast cancer chemoresistance: emerging importance of cancer stem cells.
@en
Breast cancer chemoresistance: emerging importance of cancer stem cells.
@nl
P2093
P1433
P1476
Breast cancer chemoresistance: emerging importance of cancer stem cells.
@en
P2093
Jennifer Eremin
Mohamed El-Sheemey
Oleg Eremin
Suebwong Chuthapisith
P356
10.1016/J.SURONC.2009.01.004
P577
2009-02-28T00:00:00Z